Donaldson Capital Management LLC lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,530 shares of the pharmacy operator’s stock after selling 390 shares during the quarter. Donaldson Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $355,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Reilly Financial Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 7.9% during the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares during the last quarter. Webster Bank N. A. raised its stake in shares of Walgreens Boots Alliance by 18.4% during the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after purchasing an additional 235 shares during the last quarter. Orrstown Financial Services Inc. raised its stake in shares of Walgreens Boots Alliance by 14.1% during the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares during the last quarter. MCF Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 68.2% during the first quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock worth $160,000 after purchasing an additional 780 shares during the last quarter. Finally, Founders Capital Management purchased a new stake in shares of Walgreens Boots Alliance during the first quarter worth approximately $161,000. Institutional investors own 60.16% of the company’s stock.
Several equities research analysts have recently commented on the company. Morgan Stanley cut Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $95.00 to $85.00 in a research note on Friday, October 6th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, October 5th. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Tuesday, October 3rd. Jefferies Group LLC restated a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, October 2nd. Finally, Raymond James Financial, Inc. restated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Wednesday, September 27th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have given a buy rating to the company’s stock. Walgreens Boots Alliance currently has an average rating of “Buy” and an average target price of $91.31.
In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 13.50% of the stock is currently owned by insiders.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 69.85 on Wednesday. Walgreens Boots Alliance, Inc. has a 12-month low of $69.28 and a 12-month high of $89.69. The firm has a market cap of $74.75 billion, a price-to-earnings ratio of 17.64 and a beta of 1.25. The firm has a 50-day moving average price of $79.43 and a 200 day moving average price of $80.94.
Walgreens Boots Alliance announced that its board has approved a share buyback program on Thursday, June 29th that permits the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board believes its shares are undervalued.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date of this dividend was Wednesday, August 16th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s payout ratio is currently 40.30%.
TRADEMARK VIOLATION NOTICE: “Donaldson Capital Management LLC Trims Holdings in Walgreens Boots Alliance, Inc. (WBA)” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.com-unik.info/2017/10/11/donaldson-capital-management-llc-trims-holdings-in-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
What are top analysts saying about Walgreens Boots Alliance Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance Inc. and related companies.